In terms of revenue, the global whistleblowing software market was valued at US$ 81.16 billion in 2019 and is expected to grow at a CAGR of 9.6% during the forecast period to reach US$ 149.30 billion by 2027.
The whistleblowing software can be implemented through online as well as mobile-based applications and allows two-way anonymous communication.It also provides tools to organizations to receive reports and investigate claims; analytics tools help determine the prevalence of misconduct.
Moreover, whistleblowers, who are at risk, use encryption methods and anonymous content-sharing software to protect their identity from those who are exposed.For instance, Tor, a highly accessible anonymity network, is used widely by whistleblowers around the world.
Tor has undergone several major security updates, protecting potential whistleblowers’ identities who may wish to leak information anonymously.Recently, specialized whistleblowing software such as SecureDrop and GlobaLeaks are built on the Tor technology to incentivize and simplify its adoption for secure whistleblowing.
These technological advancements in software to protect identities of whistleblowers propel the growth of the whistleblowing software market.
The whistleblowing software market has been segmented on the basis of deployment type, enterprise size, and geography.Based on deployment type, the whistleblowing software market is segmented into on-premises and web-based.
Based on enterprise size, the market has been segmented into large enterprise and SMEs. Geographically, the whistleblowing software market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America.
Business Keeper AG; Canary Whistleblowing System; Convercent; Deloitte; Ethicontrol; Ethics Global, LLC; Got Ethics A/S; Hello Ethics (ILLIX USA LLC); NAVEX Global, Inc.; and Whispli Inc. are among the well-established players in the whistleblowing software market.
Impact of COVID-19 Pandemic on Whistleblowing Software Market The continuous increase in the count of infected patients across the world has hampered the growth of various industries.The US, India, Brazil, Russia, South Africa, and Mexico, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths.
As per the latest Worldometer figures, the confirmed COVID-19 patient count accounted for 28,029,549 and 908,046 deaths globally.The COVID-19 outbreak has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.
The COVID-19 outbreak has created challenges for the whistleblowing program.The remote working has generated major challenges, which limits the organization’s visibility of employee issues and disputes, thereby hindering the effectiveness of normal channels of reporting for staff to flag issues.
Moreover, there may be delays or failure to respond to the reports made by the employees as the people involved in the whistleblowing program might have other critical strategic responsibilities. Also, the third parties involved in the whistleblowing programs might not be able to perform efficiently as they might experience disruptions in their operations due to this pandemic. With the imposition of lockdown across countries in North America, Europe, APAC, MEA, and SAM, several sectors have been witnessing shattering experience. Moreover, the companies are cutting their IT spending, which might affect the sales of the whistleblowing software. Therefore, COVID-19 is expected to have a short term impact on the whistleblowing software market.
Overall size of the whistleblowing software market is derived using primary and secondary sources.The research process begins with extensive secondary research using internal and external sources to obtain qualitative and quantitative information related to the whistleblowing software market.
It also provides the overview and forecast for the global whistleblowing software market based on all segmentation provided concerning five primary reasons such as North America, Europe, Asia Pacific, Middle East & Africa, and South America.Also, primary interviews were conducted with industry participants and commentators to validate and analyze the data.
The participants who take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, and external consultants such as valuation experts, research analysts, and key opinion leaders specialized in the whistleblowing software market.
Our reports have been used by over 10K customers, including:
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Abstract Fleet Telematics Systems Procurement in the US This report is intended to assist buyers of fleet telematics systems. Fleet telematics systems are used to monitor, map and track vehicle fleets in the field. Digital maps and Global Positioning System (GPS) technology allow for real-time visualization...
Anatomic pathology market to register a CAGR of 7.1% from 2020 to 2025. The global anatomic pathology market size is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer...
Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market. The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier...
The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period.As per World health organization in 2016, 13% of...
Anatomic pathology track and trace solutions market projected to grow at a CAGR of 10.4% The anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4% from 2018 to 2023. The increasing volume of diagnostic tests performed in anatomic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.